VOYA Investment Management’s Amylyx Pharmaceuticals AMLX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $125K | Buy |
+19,476
| New | +$125K | ﹤0.01% | 2437 |
|
|
2024
Q2 | – | Sell |
-17,357
| Closed | -$49.3K | – | 2827 |
|
|
2024
Q1 | $49.3K | Sell |
17,357
-2,818
| -14% | -$8K | ﹤0.01% | 2729 |
|
|
2023
Q4 | $297K | Sell |
20,175
-1,125,613
| -98% | -$16.6M | ﹤0.01% | 2353 |
|
|
2023
Q3 | $21M | Buy |
1,145,788
+208,248
| +22% | +$3.81M | 0.02% | 490 |
|
|
2023
Q2 | $20.2M | Buy |
937,540
+318,510
| +51% | +$6.87M | 0.02% | 511 |
|
|
2023
Q1 | $18.2M | Buy |
619,030
+576,884
| +1,369% | +$16.9M | 0.02% | 552 |
|
|
2022
Q4 | $1.56M | Buy |
42,146
+28,611
| +211% | +$1.06M | ﹤0.01% | 1434 |
|
|
2022
Q3 | $381K | Buy |
+13,535
| New | +$381K | ﹤0.01% | 2199 |
|